Advancement of a Personalised Approach to Minimising Infective Complications in Cancer Care

Grant number: 1138674 | Funding period: 2018 - 2021

Completed

Abstract

Managing infections in patients with cancer have become more difficult and unpredictable because of new generation cancer therapies. Measuring the response of the immune system (immune profiling) will allow us to predict which patients will develop infection so that action such as vaccination can be taken to reduce their risk. This program will refine immune profiling to personalise infection care for cancer patients and to introduce it into hospital practice.

Related publications (3)

Correspondence on a € Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'

M Nikpour, B Teh, IP Wicks, M Pellegrini

2021-03-01

Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort study

C Lim, P Sinha, SJ Harrison, H Quach, MA Slavin, BW Teh

2021-01-01

Introduction: A multi-centre study to determine the outcomes and risks for invasive fungal disease (IFD) in myeloma (MM) patients ..

Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies

BW Teh, CS Tam, S Handunnetti, LJ Worth, MA Slavin

2018-11-01

Chronic lymphocytic leukaemia (CLL) is the most common leukaemia with infections a leading cause of morbidity and mortality. Recen..

University of Melbourne Researchers

Benjamin Teh